David S. Snyder Email & Phone Number

Chicago, IL, US

Helped prepare Coya for life as a public company and then helped Coya market and close its IPO in January of 2023. Upgraded financial reporting systems and internal controls to be SarbOx compliant. Helped negotiate and close two in-licensing transactions to secure rights to biologic assets comprising Coya's lead therapeutic. Coya Therapeutics, Inc..

Board member and Chair of Audit Committee. Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multi-specific antibodies and their derivatives. Invenra has a growing pipeline of immuno-oncology bi-specific antibodies that are currently in pre-clinical studies. Announced partnerships with Exelixsis and WARF.

Georgetown, TX, US

DisperSol is a late stage bio-pharmaceutical company with four active clinical programs. DisperSol's drug for acquired resistance prostate cancer is currently enrolling in a Phase 2 dose expansion study and the company's iron chelator is preparing to launch a Phase 3 study. The Company has two additional programs completing Phase 1 studies and NCE in.

Chicago, Illinois, US

Exicure, Inc. is a clinical-stage biotechnology company developing drugs for immuno-oncology, neurological disorders and inflammatory diseases. Exicure's 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Exicure currently has a Phase 2 asset for immuno-oncology and various.

Madison, WI, US

After successful sale of NimbleGen to Roche (see below), invited by same investor group to join this new life science start-up.CDI is commercializing stem cell technology developed by James Thomson at the University of Wisconsin. That technology (known as iPS) allows us to produce a fully pluripotent stem cell from adult skin and blood eliminating the.

US

Brought in to lead IPO. Over 18 months, helped lead "Dual Track" process that led to an S1 filing in March of 2007 followed by the sale of NimbleGen to Roche for $272 Mil... 22x revenue...in August of 2007. In addition to managing all financial operations, I had responsibility for production, customer service, technical service and quality control..

Early-stage company supplying enterprise-class software to the healthcare industry. Financing from Portage/Draper Fisher Jurvetson and Hopewell Ventures.

Responsible for all financial functions, production, order fulfillment, investor relations, legal and process improvement at this NASDAQ-traded company. Cobalt provides Internet applications to franchised automobile dealers which enable online marketing, sales, and CRM. Reduced headcount by 50. Cured imminent debt default. Closed joint venture with GE.

Joined this start-up venture three months after formation and helped lead its growth from start-up to nearly $3 billion assets. Initial equity provided by Goldman Sachs Whitehall Funds, Security Capital Group, Inc. and The Prudential Insurance Company. Strategic Hotel Capital, LLC acquires and asset manages luxury and upscale hotels. Within two years, the.

Rejoined Sam Zell’s organization to help launch a new real estate investment firm. Developed strategic plan for the business and initial operating policies and procedures. Invested over $150 million in 12 parking facilities.Managed business operations. Responsible for acquisition analysis and investment committee proposals and recommendations.

Joined this Crane Co. subsidiary shortly after Crane’s acquisition of Mark Controls (see below). Led department of 24 responsible for all financial functions at this $150 million in sales manufacturer of electronic aerospace and telecommunications components. Direct report to unit president with dotted-line responsibility to Crane's chief financial.

Jump-started growth and value creation at this NASDAQ traded manufacturer of electronic and electromechanical instruments, controls and industrial valves. Sales of $135 million up over 50% in one year. Raised $53 million and completed two acquisitions to grow the business. Negotiated $30 million term loan and $23 million revolving credit facility to.

The Equity Group is a holding company for the investment interests of Chicago real estate andfinancial entrepreneur Sam Zell. Started in investment analysis at EGI and then joined Eagle Industries. Held positions of increasing responsibility. Eagle is a diversified manufacturing company. Started acquisition group at beginning of major acquisition.

Mba

Ba, Economics